RYBELSUS cpr 14 mg 30 pce
7680674460077
CH-67446
A10BJ06
07.06.2.
Reimbursement limitations:
RYBELSUS2
Pour le traitement des patients atteints d’un diabète sucré de type 2 insuffisamment contrôlé en …
1 / 3
google
Details
- Product number
- 6744603
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- semaglutidum 14 mg, natrii salcaprozas corresp. natrium 22.9 mg, cellulosum microcristallinum, povidonum K 90, magnesii stearas, pro compresso.
Articles (1)
Rybelsus 14 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
14.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
22.9 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 126.70
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2020
Authorization holder
Novo Nordisk Pharma AG
8302 Kloten
Authorization information
- Swissmedic authorization number
- 67446
- Drug name
- Rybelsus, Tabletten
- Galenic form
- TAB
- ATC Code
- A10BJ06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 24/03/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RYBELSUS cpr 14 mg 30 pce
- Description (DE)
- RYBELSUS Tabl 14 mg 30 Stk
- Market launch
- 24/03/2020
- Narcotic (BTM)
- No